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Methods: This	 was	 a	 randomized,	 double-blind	 study.	 Adults	 (age:	 18–60	 years)	
scheduled	for	dLP	were	included.	dLP	and	CSF	acquisition	were	performed	in	accord-
ance with highly standardized procedures. Patients were followed up on days 2 and 7.
Results: In	total,	172	patients	were	randomized	and	lumbar	punctured,	and	21	were	
excluded	due	to	wrong	inclusion	(n =	11),	needle	switch	(n =	7),	failed	dLP	(n =	1),	
withdrawal	(n =	1),	and	missed	follow-up	(n =	1).	Among	the	remaining	151	patients	
(mean	age:	40.7	±	12.4	years),	77	had	dLP	using	22GQ	and	74	using	22GS.	Incidence	
of	 PDPH	 among	 patients	 punctured	 with	 22GS	 (18%)	 was	 significantly	 lower	
(p =	.004)	than	among	patients	punctured	with	22GQ	(39%).	Relative	risk	was	0.45,	
95%	CI	0.26–0.80.	Patients	with	PDPH	had	significantly	lower	weight	(p =	.035),	and	
there	was	no	significant	difference	related	to	age	(p =	 .064),	sex	(p =	 .239),	height	
(p =	.857),	premorbid	episodic	migraine	(p =	.829),	opening	pressure	(p =	.117),	opera-
tors	(p =	.148),	amount	of	CSF	removed	(p =	.205),	or	number	of	attempts	(p =	.623).
Conclusions: The	use	of	22GS	halves	the	risk	of	PDPH	compared	with	22GQ.	This	
study provides strong support to make a change in practice where traumatic needles 
are still in regular use.
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1  | INTRODUC TION
Diagnostic	 lumbar	 puncture	 (dLP)	 is	 probably	 one	 of	 the	 most	
commonly performed invasive procedures in clinical medicine. It 
is	easy	to	master,	highly	available,	and	permits	direct	access	to	the	
environment	 of	 the	 central	 nervous	 system	 (CNS).	 The	 procedure	
is	 essential,	 and	 the	 indications	 are	 many,	 to	 exclude	 subarach-
noid	hemorrhage	in	acute	headache	(Sjulstad	&	Alstadhaug,	2019),	
measure	 intracranial	 pressure,	 and	 investigate	CNS	 infections	 and	
a	large	number	of	neurological	disorders.	dLP	is	generally	safe,	but	
a	 common	 complication	 is	 postdural	 puncture	 headache	 (PDPH),	
first	 described	 in	1898.	 (Bier,	 1899)	 Several	 studies	 comparing	 in-
cidence of PDPH when using atraumatic and traumatic needles 
(Arevalo-Rodriguez	et	al.,	2017;	Nath	et	al.,	2018)	have	confirmed	
a clear benefit of the atraumatic needle. Other benefits reported 
with using atraumatic needles are reduced need for epidural blood 
patch and treatment with intravenous fluids and analgesics. In other 
studies,	reduction	 in	the	 incidence	of	both	mild	and	severe	PDPH,	
any	 headache,	 nerve	 root	 irritation,	 and	 hearing	 disturbances	 has	
been	shown.	(Nath	et	al.,	2018)	It	has	earlier	been	pointed	out	that	
failure to switch from the traditional to the atraumatic needle was 
due	to	lack	of	communication	(“diffusion	of	innovation”)	rather	than	
evidence and that neurologists compared with anesthetists are more 
prone	to	this.	A	common	perception	is	that	using	atraumatic	needles	
are	more	 complex.	 Furthermore,	 the	 complexity	 of	 innovation	 af-
fects the likelihood of its adoption. The first studies published show-
ing a reduced incidence of PDPH following the use of atraumatic 






In	 a	 Cochrane	 report	 from	 2017,	 however,	 it	 was	 pointed	 out	
that	the	quality	of	evidence	is	moderate	and	that	“further	research	is	
likely to have an important impact on our confidence in the estimate 
of	effect.”	In	our	opinion,	poor	evaluation	of	headaches,	both	prior	
to	the	dLP	and	afterward,	is	potentially	one	of	the	greatest	biases	in	
previous randomized controlled studies.
The	22G	needle	is	considered	most	appropriate	for	dLP	(Armon	
&	 Evans,	 2005),	 and	we	wanted	 to	 do	 a	 new	methodically	 robust	
study	of	the	beneficial	effect	of	atraumatic	needle	in	dLP,	hoping	to	
convince the neurological societies to change practice where trau-





2.2 | Standard protocol approvals, trial 
registration, and participant consents
The study was approved by the Regional Committee for Medical and 
Health	Research	Ethics	(REK	nord	2011/1083).	The	trial	was	registered	










were recruited during their admission/visit to the Department of 
Neurology	at	Nordland	Hospital	 in	Bodø,	Norway.	They	had	to	be	
between 18 and 60 years of age. The doctor performing the proce-
dure	 informed	the	patients,	and	they	got	a	consent	form	including	
study information.









Informed consenting patients were randomized in two groups based 
on	needle	 type.	 The	CONSORT	 flow	diagram	 (Figure	 1)	 shows	 the	
progress	through	this	parallel-designed	trial	where	one	group	being	
lumbar	punctured	with	Spinocan®	(Quincke)	22Gx3,5	needle,	and	the	






The procedure was performed in accordance with highly standard-
ized	 and	 established	 procedures	 (see	 below).	 Patients	 were	 blinded	
to the randomization and needle type. The performing resident knew 
which needle was being used for obvious reasons. Physicians per-
forming	 the	 dLP	were	 not	 involved	 in	 patient	 follow-up,	 which	was	
performed by investigators blinded to the randomization. Patients 
were	contacted	by	phone;	 if	they	still	were	admitted	to	the	hospital,	
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the	interview	was	done	bedside,	on	days	2	and	7	after	the	dLP.	If	the	















The patient was positioned in a lateral decubitus position during the 
procedure.	 Some	 of	 the	most	 anxious	 patients	were	 treated	with	
local	 anesthetics,	 lidocaine	1%.	When	using	 the	 traumatic	needle,	
the bevel was parallel to the longitudinal axis of the spine during 
insertion. The needle was then slightly angled and aimed toward 
the	 navel.	 The	 quantity	 of	 CSF	 was	 determined	 by	 the	 analyses	




patient in a sitting position. Each patient had 30 min of bed rest after 
the	procedure.	Patients	were	included	only	on	weekdays	(Monday–
Friday),	between	07.30	a.m.	and	4.00	p.m.
F I G U R E  1  Flow	diagram.	Occurrence	of	postdural	puncture	headache—an	RCT	comparing	22G	Sprotte and Quincke
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2.6 | Outcomes
The	primary	outcome	was	the	occurrence	of	PDPH.	Secondary	out-
comes were potential risk factors for developing PDPH as listed in 
Table	1.	Headaches,	both	prior	to	LP	and	on	days	2	and	7	after	the	
procedure,	 were	 diagnosed	 in	 accordance	 with	 the	 international	
criteria	 (Headache	 Classification	 Committee	 of	 the	 International	
Headache	 Society)	 (Headache	 Classification	 Subcommittee	 of	 the	








ies,	 the	 incidence	 of	 PDPH	was	 significantly	 higher	 in	 the	 cutting	
needle	group	than	in	the	atraumatic	group,	from	36%	versus	3%	(Lavi	
et	al.,	2006)	to	24.4%	versus	12.2%.	(Strupp	et	al.,	2001)	With	a	90%	






of	172	would	be	 appropriate.	Data	were	 analyzed	with	 IBM	SPSS	










inally anticipated. The number of eligible patients assessed for par-
ticipation	was	not	recorded,	nor	the	number	of	subjects	not	meeting	
the inclusion criteria. None of the patients asked for participation 
declined.	 In	total,	172	patients	were	recruited	and	randomized.	Of	




and baseline characteristics of the included are shown in Table 1 and 
that of the excluded are in Table 3.
Of	included	patients,	77	were	lumbar	punctured	with	22GQ	and	
74	with	22GS.	In	total,	43	patients	developed	a	headache	that	met	
TA B L E  1   Demographic data and potential risk factors for 













Weight,	kg 72.5	± 16.3 79.1 ± 17.6 .035
Height,	m 1.73 ± 0.09 1.73 ± 0.09 .857












1.5	± 0.7 1.4	± 0.8 .623a 
Opening	pressure,	cm	
H2O
15.8	±	4.9 17.2 ±	4.6 .117
CSF	removed,	ml 7.7 ±	3.4 8.5	± 3.8 .205a 
CSF	glucose,	mmol/L 3.4	± 0.3 3.5	±	0.5 .193a 
CSF	total	protein,	mg 0.4	± 0.1 0.4	± 0.3 .288a 
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the	IHS	criteria	for	PDPH.	Of	the	patients	with	PDPH,	13	were	punc-
tured with the atraumatic needle and 30 with the traumatic needle 
(Figure	 2).	 The	 incidence	 of	 PDPH	 among	 the	 patients	 punctured	







(p =	.239),	height	(p =	.857),	opening	pressure	(p =	.117),	operators	
(p =	 .148),	 amount	 CSF	 removed	 (p =	 .205),	 number	 of	 attempts	
















among	 British	 neurologists	 is	 probably	 not	 much	 higher	 (Davis	
et	 al.,	 2016).	Our	 data	 confirm	 the	 result	 of	 previous	 studies;	 the	
use	of	22GS	spinal	needles	causes	significantly	fewer	patients	hav-
ing PDPH.
As	 stated	 earlier,	 we	 believe	 that	 poor	 evaluation	 of	 the	 pa-
tientsˈ	 headaches	 is	 one	 of	 the	 greatest	 biases	 in	 previous	 RCTs.	
Furthermore,	just	a	couple	of	studies	published	in	the	last	10	years	
were	RCTs	where	patients	were	having	dLP	 (Castrillo	et	al.,	2015;	
Salzer	 et	 al.,	 2020),	 and	 not	 lumbar	 punctured	 because	 of	 other	
indications such as myelography or anesthesia. Most of the older 
RCTs	have	less	than	100	participants	(Lavi	et	al.,	2006;	Luostarinen	









of our study. It is also known that the incidence of PDPH in patients 
older than 60 years is much lower than in the younger population and 
rare	in	children	(Amorim	et	al.,	2012;	Evans	et	al.,	2000;	Khlebtovsky	
et	 al.,	 2015;	Wadud	 et	 al.,	 2006).	 Patients	 included	 in	 our	 study	
were	 in	 the	 age-group	with	 the	 highest	 risk	 of	 developing	 PDPH.	
As	 also	demonstrated	 in	 earlier	 studies	 (Evans	 et	 al.,	 2000;	Kuntz	
et	al.,	1992;	Lavi	et	al.,	2006;	Lynch	et	al.,	1991;	Wadud	et	al.,	2006),	
we	found	that	low	BMI	causes	increased	prevalence	of	PDPH.	Our	






(n = 17) p-value




Weight,	kg 95	±	42.4 80.1 ± 16.8 0.323b 
Height,	m 1.8 ± 0.08 1.8 ± 0.08 0.661b 












3.7 ±	2.5 2.8 ± 2.3 0.565b 
Opening	pressure,	cm	
H2O
18.8 ±	2.5 16.4	±	5.9 0.598b 
CSF	removed,	ml 7.7 ±	2.5 6.7 ± 2.2 0.48
CSF	glucose,	mmol/L 3.4 3.5	± 0.2 0.752b 
CSF	total	protein,	mg 0.4	± 0.1 0.5	± 0.2 0.284








F I G U R E  2  Bar	plot	showing	the	distribution	of	PDPH	when	
using traumatic versus atraumatic needle
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data	seem	to	indicate	that	the	female	gender	is	a	risk	factor,	however	
not significantly. Previous studies have shown that women are twice 
as	much	at	 risk	of	getting	PDPH	as	men	 (Dripps	&	Vandam,	1954;	
Evans	et	al.,	2000).	Patients	with	premorbid	episodic	migraine	were	
not at a higher risk of developing PDPH.
Our	study	was	extended	over	a	relatively	long	time	period,	and	
12%	 of	 allocated	 participants	 were	 eventually	 excluded	 from	 the	
final	outcome	analyses.	Including	these,	however,	does	not	change	
the	 results.	 In	 the	 early	 phase	 of	 the	 study,	 recruitment	 and	 LPs	








be an explanation to this as the learning curve between traumatic 
and	atraumatic	LP	is	not	different	(Vakharia	&	Lote,	2012),	and	the	
fact that residents report preferring using atraumatic needle after 
completing	training	using	a	simulator	(Tung,	2013).
It	 seems	 like	 the	 use	 of	 the	 traumatic	 needle	 is	 still	 frequent	
among	 neurologists,	 particularly	 in	 Europe	 (Davis	 et	 al.,	 2016;	
Moisset	et	al.,	2016).	The	anesthesia	community	in	the	United	States	
changed	their	practice	to	the	use	of	atraumatic	needles	in	the	1990s,	
despite the fact that many studies demonstrated the advantage of 
noncutting needles years before. The neurologic community in the 
United	States	was	apparently	not	 influenced	by	these	studies,	and	
they	spent	many	years	to	change	their	practice.	In	2002,	atraumatic	
needles were introduced and made available at the Department of 
Neurology	 at	 the	Mayo	Clinic	 in	Arizona.	Over	 the	 years,	 the	 use	
of	 the	 atraumatic	 needles	 slowly	 increased	 among	 the	 American	
neurology	community	(Arendt	et	al.,	2009).	We	hope	that	our	study	
finally will cause other neurological communities to adopt this prac-
tice as well.
In	conclusion,	 the	use	of	22G	atraumatic	needle	 for	diagnostic	
lumbar puncture reduces the incidence of postdural puncture head-
ache	with	 almost	50%	when	 compared	with	 the	use	of	22G	 trau-
matic needle.
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